79 related articles for article (PubMed ID: 166088)
1. Failure of somatostatin to inhibit tolbutamide-induced insulin secretion in patients with insulinomas: a possible diagnostic tool.
Lorenzi M; Gerich JE; Karam JH; Forsham PH
J Clin Endocrinol Metab; 1975 Jun; 40(6):1121-4. PubMed ID: 166088
[TBL] [Abstract][Full Text] [Related]
2. [Tolbutamide plus somatostatin test in the diagnosis of insulinomas].
Jara Albarrán A; Caballero Asensi A; García Peris P; Coste A; Toledano E; Gorospe C; Caviola E; Palacios Mateos JM
Rev Clin Esp; 1982 Jan; 164(2):105-9. PubMed ID: 6124027
[No Abstract] [Full Text] [Related]
3. Inhibition by somatostatin of tolbutamide-induced insulin secretion in a patient with an insulinoma.
Van Kersen F
Neth J Med; 1976; 19(1):5-7. PubMed ID: 175307
[No Abstract] [Full Text] [Related]
4. Effects of somatostatin on insulin and glucagon in patients with insulinoma.
Fallucca F; Mirabella C; Tamburrano G; Gambardella S; Aufieri G; Barbetti F; Andreani D
J Endocrinol Invest; 1979; 2(3):257-60. PubMed ID: 231062
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological modifications of insulin release in vitro from fuel-responsive transplantable insulinomas.
Hoenig M; Ferguson DC; Matschinsky FM
Endocrinology; 1984 Oct; 115(4):1496-9. PubMed ID: 6148233
[TBL] [Abstract][Full Text] [Related]
6. Insulin, proinsulin, glucagon and gastrin in pancreatic tumors and in plasma of patients with organic hyperinsulinism.
Hayashi M; Floyd JC; Pek S; Fajans SS
J Clin Endocrinol Metab; 1977 Apr; 44(4):681-94. PubMed ID: 14970
[TBL] [Abstract][Full Text] [Related]
7. Somatostatin inhibition of insulin secretion in insulin-producing tumors.
Scuro LA; Lo Cascio V; Adami S; Galvanini G; Bianchi I; Cominacini L; Corgnati A
Metabolism; 1976 Jun; 25(6):603-9. PubMed ID: 178978
[No Abstract] [Full Text] [Related]
8. Response of islet cell tumors to enterohormones.
Fallucca F; Tamburrano S; Gambardella S; Menzinger G
Horm Metab Res; 1976; Suppl 6():34-9. PubMed ID: 179927
[TBL] [Abstract][Full Text] [Related]
9. Role of insulin and glucose in the induction of hypoaminoacidemia in man: studies in normal, juvenile diabetic, and insuloma patients.
Adibi SA; Morse EL; Amin PM
J Lab Clin Med; 1975 Sep; 86(3):395-409. PubMed ID: 168278
[TBL] [Abstract][Full Text] [Related]
10. Five cases of somatostatinoma: clinical heterogeneity and diagnostic usefulness of basal and tolbutamide-induced hypersomatostatinemia.
Pipeleers D; Couturier E; Gepts W; Reynders J; Somers G
J Clin Endocrinol Metab; 1983 Jun; 56(6):1236-42. PubMed ID: 6132927
[TBL] [Abstract][Full Text] [Related]
11. Hyperinsulinemic hypoglycemia: effect of epinephrine suppression.
Kansal PC; Boshell BR; Buse J; Bandisode MS; Roddam RF; Buse MG
Horm Metab Res; 1977 Nov; 9(6):510-2. PubMed ID: 201552
[TBL] [Abstract][Full Text] [Related]
12. Islet cell tumors of the pancreas.
Williams C
Va Med Mon (1918); 1969 Mar; 96(3):127-32. PubMed ID: 4307057
[No Abstract] [Full Text] [Related]
13. [Tolbutamide loading test].
Goto Y; Umezu M
Nihon Rinsho; 1979 Jun; Suppl():2624-5. PubMed ID: 226755
[No Abstract] [Full Text] [Related]
14. Pancreatic glucagon-like immunoreactivity in a pancreatectomized patient.
Botha JL; Vinik AI; Child PT; Paul M; Jackson WP
Horm Metab Res; 1977 May; 9(3):199-205. PubMed ID: 885471
[TBL] [Abstract][Full Text] [Related]
15. [Biochemical diagnosis of insulinoma: correlations between blood glucose, blood insulin and the titer of plasma non-esterified fatty acids during fasting and during various diagnostic tests].
Gorini M; Ghizzi A; Carlo Stella C; De Caro L
Minerva Med; 1985 Sep; 76(37):1663-75. PubMed ID: 2995870
[TBL] [Abstract][Full Text] [Related]
16. Acute suppressive effect of human growth hormone on insulin release induced by glucagon and tolbutamide in man.
Adamson U; Cerasi E
Diabete Metab; 1975 Mar; 1():51-6. PubMed ID: 1234067
[TBL] [Abstract][Full Text] [Related]
17. The use of artificial beta cell in diagnosis and treatment of insulinoma.
Raptis S; Zoupas C; Dimitriadis G; Moulopoulos S
Horm Metab Res Suppl; 1979; (8):169-72. PubMed ID: 231567
[TBL] [Abstract][Full Text] [Related]
18. Use of somatostatin and somatostatin analogs in a patient with a glucagonoma.
Kahn CR; Bhathena SJ; Recant L; Rivier J
J Clin Endocrinol Metab; 1981 Sep; 53(3):543-9. PubMed ID: 6114963
[No Abstract] [Full Text] [Related]
19. [Behavior of plasma glucagon in experimental fasting and somatostatin test in islet cell tumors].
Drost H; Berger M; Berchtold P; Wiegelmann W; Zimmermann H; Gries FA
Med Welt; 1976 Jul; 27(28):1381-3. PubMed ID: 183080
[No Abstract] [Full Text] [Related]
20. [Clinical significance of insulin determination].
Schauder P; Frerichs H
Med Klin; 1978 Feb; 73(7):217-23. PubMed ID: 203830
[No Abstract] [Full Text] [Related]
[Next] [New Search]
